A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Previous trials of intravenous immunoglobulin (IvIg) treatment of women with recurrent miscarriage (RM) have provided diverging results. This may be due to different inclusion criteria and suboptimal treatment protocols in some trials. METHODS: According to a computer-generated list, 58 women with at least four unexplained miscarriages were randomly assigned to receive infusions of high doses of IvIg or placebo starting as soon as the pregnancy test was positive. RESULTS: In the intention-to-treat analysis, a 45% live birth rate was found in both allocation groups. In patients with secondary RM, 50% in the treatment group and 23% in the placebo group had successful pregnancies (P = not significant). When data from the present and a previous placebo-controlled trial of the same treatment were combined, 15/26 (58%) of the patients with secondary RM in the treatment group versus 6/26 (24%) in the placebo group had successful outcomes (P < 0.02). Only 7% of the karyotyped abortuses were abnormal. CONCLUSIONS: IvIg may improve pregnancy outcome in patients with secondary RM. A new placebo-controlled trial focusing on this subgroup should be conducted to confirm the results.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Embryonic karyotype of abortuses in relation to the number of previous miscarriages
Ogasawara, M., Aoki, K., Okada, S., & Suzumori, K. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00495-1 · Cited by 604 · cited 2×
“This is in accordance with other studies of fetal chromosome anomaly in RM, and emphasizes the fact that fetal aneuploidy is an infrequent cause of miscarriages in patients with multiple (e.g. four or more) miscarriages (Ho et al., 1991; Ogasawara et al., 2000).”
Cited by
Update on the use of immunoglobulin in human disease: A review of evidence
Perez, E. E., Orange, J. S., Bonilla, F., Chinen, J., Chinn, I. K., Dorsey, M., El-Gamal, Y., Harville, T. O., Hossny, E., Mazer, B., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.023 · Cited by 666
Exposure to bisphenol A is associated with recurrent miscarriage
Sugiura-Ogasawara, M., Ozaki, Y., Sonta, S.-I., Makino, T., & Suzumori, K. (2005) · Human Reproduction · doi:10.1093/humrep/deh888 · Cited by 405
Dosiou, C., & Giudice, L. C. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0021 · Cited by 391
Immunotherapy for recurrent miscarriage
Wong, L. F., Porter, T. F., & Scott, J. R. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000112.pub3 · Cited by 348
Evidence-based investigations and treatments of recurrent pregnancy loss
Christiansen, O. B., Nybo Andersen, A.-M., Bosch, E., Daya, S., Delves, P. J., Hviid, T. V., Kutteh, W. H., Laird, S. M., Li, T.-C., & van der Ven, K. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.12.018 · Cited by 302
Self-citation
Metadata
- Authors
- Christiansen, O. B., Pedersen, B., Rosgaard, A., & Husth, M.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-03-01
- Volume
- 17
- Issue
- 3
- Pages
- 809-816
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2125359865
- Cited by
- 152
- References
- 1
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. https://app.cochat.ai/papers/10.1093/humrep/17.3.809
- The paper
- Christiansen, O. B., Pedersen, B., Rosgaard, A., & Husth, M. (2002). A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Human Reproduction. https://doi.org/10.1093/humrep/17.3.809
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.